Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation.

Iuliani, Michele; Simonetti, Sonia; Ribelli, Giulia; Cavaliere, Silvia; Vincenzi, Bruno; Tonini, Giuseppe; Pantano, Francesco; Santini, Daniele

Iuliani, Michele; Simonetti, Sonia; Ribelli, Giulia; Cavaliere, Silvia; Vincenzi, Bruno; Tonini, Giuseppe; Pantano, Francesco; Santini, Daniele.

Afiliação

Iuliani M; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Simonetti S; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Ribelli G; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Cavaliere S; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Vincenzi B; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Tonini G; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Pantano F; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Santini D; Department of Medical Oncology, Campus Bio-Medico University of Rome, 00128 Rome, Italy.

Biomedicines ; 10(9)2022 Sep 01.

Article em En | MEDLINE | ID: mdl-36140255

Palavras-chave

abiraterone; androgen receptor; castration-resistant prostate cancer (CRPC) cells; osteoblasts

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google